H. Gezmis Et Al. , "CD4+and CD25+T-cell response to short-time interferon-beta therapy on IL10, IL23A and FOXP3 genes in multiple sclerosis patients," INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , vol.75, 2021
Gezmis, H. Et Al. 2021. CD4+and CD25+T-cell response to short-time interferon-beta therapy on IL10, IL23A and FOXP3 genes in multiple sclerosis patients. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , vol.75 .
Gezmis, H., Doran, T., Mayda Domac, F., Yücel, D., Karaci, R., & Kirac, D., (2021). CD4+and CD25+T-cell response to short-time interferon-beta therapy on IL10, IL23A and FOXP3 genes in multiple sclerosis patients. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , vol.75.
Gezmis, Hazal Et Al. "CD4+and CD25+T-cell response to short-time interferon-beta therapy on IL10, IL23A and FOXP3 genes in multiple sclerosis patients," INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , vol.75, 2021
Gezmis, Hazal Et Al. "CD4+and CD25+T-cell response to short-time interferon-beta therapy on IL10, IL23A and FOXP3 genes in multiple sclerosis patients." INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , vol.75, 2021
Gezmis, H. Et Al. (2021) . "CD4+and CD25+T-cell response to short-time interferon-beta therapy on IL10, IL23A and FOXP3 genes in multiple sclerosis patients." INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , vol.75.
@article{article, author={Hazal Gezmis Et Al. }, title={CD4+and CD25+T-cell response to short-time interferon-beta therapy on IL10, IL23A and FOXP3 genes in multiple sclerosis patients}, journal={INTERNATIONAL JOURNAL OF CLINICAL PRACTICE}, year=2021}